Report Detail

Pharma & Healthcare Global Hormone Refractory Prostate Cancer (HRPCA) Market Professional Survey Report 2019

  • RnM3812608
  • |
  • 11 October, 2019
  • |
  • Global
  • |
  • 100 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    Executive Summary

      1 Industry Overview of Hormone Refractory Prostate Cancer (HRPCA)

      • 1.1 Definition of Hormone Refractory Prostate Cancer (HRPCA)
      • 1.2 Hormone Refractory Prostate Cancer (HRPCA) Segment by Type
        • 1.2.1 Global Hormone Refractory Prostate Cancer (HRPCA) Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Chemotherapy
        • 1.2.3 Hormonal Therapy
        • 1.2.4 Immunotherapy
        • 1.2.5 Radiation Therapy
        • 1.2.6 Surgery
      • 1.3 Hormone Refractory Prostate Cancer (HRPCA) Segment by Applications
        • 1.3.1 Global Hormone Refractory Prostate Cancer (HRPCA) Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Ambulatory Surgical Centers
        • 1.3.4 Specialty Clinics
      • 1.4 Global Hormone Refractory Prostate Cancer (HRPCA) Overall Market
        • 1.4.1 Global Hormone Refractory Prostate Cancer (HRPCA) Revenue (2014-2025)
        • 1.4.2 Global Hormone Refractory Prostate Cancer (HRPCA) Production (2014-2025)
        • 1.4.3 North America Hormone Refractory Prostate Cancer (HRPCA) Status and Prospect (2014-2025)
        • 1.4.4 Europe Hormone Refractory Prostate Cancer (HRPCA) Status and Prospect (2014-2025)
        • 1.4.5 China Hormone Refractory Prostate Cancer (HRPCA) Status and Prospect (2014-2025)
        • 1.4.6 Japan Hormone Refractory Prostate Cancer (HRPCA) Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Hormone Refractory Prostate Cancer (HRPCA) Status and Prospect (2014-2025)
        • 1.4.8 India Hormone Refractory Prostate Cancer (HRPCA) Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Hormone Refractory Prostate Cancer (HRPCA)
      • 2.3 Manufacturing Process Analysis of Hormone Refractory Prostate Cancer (HRPCA)
      • 2.4 Industry Chain Structure of Hormone Refractory Prostate Cancer (HRPCA)

      3 Development and Manufacturing Plants Analysis of Hormone Refractory Prostate Cancer (HRPCA)

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Hormone Refractory Prostate Cancer (HRPCA) Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Hormone Refractory Prostate Cancer (HRPCA)
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Hormone Refractory Prostate Cancer (HRPCA) Production and Capacity Analysis
      • 4.2 Hormone Refractory Prostate Cancer (HRPCA) Revenue Analysis
      • 4.3 Hormone Refractory Prostate Cancer (HRPCA) Price Analysis
      • 4.4 Market Concentration Degree

      5 Hormone Refractory Prostate Cancer (HRPCA) Regional Market Analysis

      • 5.1 Hormone Refractory Prostate Cancer (HRPCA) Production by Regions
        • 5.1.1 Global Hormone Refractory Prostate Cancer (HRPCA) Production by Regions
        • 5.1.2 Global Hormone Refractory Prostate Cancer (HRPCA) Revenue by Regions
      • 5.2 Hormone Refractory Prostate Cancer (HRPCA) Consumption by Regions
      • 5.3 North America Hormone Refractory Prostate Cancer (HRPCA) Market Analysis
        • 5.3.1 North America Hormone Refractory Prostate Cancer (HRPCA) Production
        • 5.3.2 North America Hormone Refractory Prostate Cancer (HRPCA) Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Hormone Refractory Prostate Cancer (HRPCA) Import and Export
      • 5.4 Europe Hormone Refractory Prostate Cancer (HRPCA) Market Analysis
        • 5.4.1 Europe Hormone Refractory Prostate Cancer (HRPCA) Production
        • 5.4.2 Europe Hormone Refractory Prostate Cancer (HRPCA) Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Hormone Refractory Prostate Cancer (HRPCA) Import and Export
      • 5.5 China Hormone Refractory Prostate Cancer (HRPCA) Market Analysis
        • 5.5.1 China Hormone Refractory Prostate Cancer (HRPCA) Production
        • 5.5.2 China Hormone Refractory Prostate Cancer (HRPCA) Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Hormone Refractory Prostate Cancer (HRPCA) Import and Export
      • 5.6 Japan Hormone Refractory Prostate Cancer (HRPCA) Market Analysis
        • 5.6.1 Japan Hormone Refractory Prostate Cancer (HRPCA) Production
        • 5.6.2 Japan Hormone Refractory Prostate Cancer (HRPCA) Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Hormone Refractory Prostate Cancer (HRPCA) Import and Export
      • 5.7 Southeast Asia Hormone Refractory Prostate Cancer (HRPCA) Market Analysis
        • 5.7.1 Southeast Asia Hormone Refractory Prostate Cancer (HRPCA) Production
        • 5.7.2 Southeast Asia Hormone Refractory Prostate Cancer (HRPCA) Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Hormone Refractory Prostate Cancer (HRPCA) Import and Export
      • 5.8 India Hormone Refractory Prostate Cancer (HRPCA) Market Analysis
        • 5.8.1 India Hormone Refractory Prostate Cancer (HRPCA) Production
        • 5.8.2 India Hormone Refractory Prostate Cancer (HRPCA) Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Hormone Refractory Prostate Cancer (HRPCA) Import and Export

      6 Hormone Refractory Prostate Cancer (HRPCA) Segment Market Analysis (by Type)

      • 6.1 Global Hormone Refractory Prostate Cancer (HRPCA) Production by Type
      • 6.2 Global Hormone Refractory Prostate Cancer (HRPCA) Revenue by Type
      • 6.3 Hormone Refractory Prostate Cancer (HRPCA) Price by Type

      7 Hormone Refractory Prostate Cancer (HRPCA) Segment Market Analysis (by Application)

      • 7.1 Global Hormone Refractory Prostate Cancer (HRPCA) Consumption by Application
      • 7.2 Global Hormone Refractory Prostate Cancer (HRPCA) Consumption Market Share by Application (2014-2019)

      8 Hormone Refractory Prostate Cancer (HRPCA) Major Manufacturers Analysis

      • 8.1 Astellas Inc
        • 8.1.1 Astellas Inc Hormone Refractory Prostate Cancer (HRPCA) Production Sites and Area Served
        • 8.1.2 Astellas Inc Product Introduction, Application and Specification
        • 8.1.3 Astellas Inc Hormone Refractory Prostate Cancer (HRPCA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Sanofi S.A
        • 8.2.1 Sanofi S.A Hormone Refractory Prostate Cancer (HRPCA) Production Sites and Area Served
        • 8.2.2 Sanofi S.A Product Introduction, Application and Specification
        • 8.2.3 Sanofi S.A Hormone Refractory Prostate Cancer (HRPCA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Dendreon Corporation, Bayer AG
        • 8.3.1 Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer (HRPCA) Production Sites and Area Served
        • 8.3.2 Dendreon Corporation, Bayer AG Product Introduction, Application and Specification
        • 8.3.3 Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer (HRPCA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Johnson & Johnson
        • 8.4.1 Johnson & Johnson Hormone Refractory Prostate Cancer (HRPCA) Production Sites and Area Served
        • 8.4.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.4.3 Johnson & Johnson Hormone Refractory Prostate Cancer (HRPCA) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served

      9 Development Trend of Analysis of Hormone Refractory Prostate Cancer (HRPCA) Market

      • 9.1 Global Hormone Refractory Prostate Cancer (HRPCA) Market Trend Analysis
        • 9.1.1 Global Hormone Refractory Prostate Cancer (HRPCA) Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Hormone Refractory Prostate Cancer (HRPCA) Regional Market Trend
        • 9.2.1 North America Hormone Refractory Prostate Cancer (HRPCA) Forecast 2019-2025
        • 9.2.2 Europe Hormone Refractory Prostate Cancer (HRPCA) Forecast 2019-2025
        • 9.2.3 China Hormone Refractory Prostate Cancer (HRPCA) Forecast 2019-2025
        • 9.2.4 Japan Hormone Refractory Prostate Cancer (HRPCA) Forecast 2019-2025
        • 9.2.5 Southeast Asia Hormone Refractory Prostate Cancer (HRPCA) Forecast 2019-2025
        • 9.2.6 India Hormone Refractory Prostate Cancer (HRPCA) Forecast 2019-2025
      • 9.3 Hormone Refractory Prostate Cancer (HRPCA) Market Trend (Product Type)
      • 9.4 Hormone Refractory Prostate Cancer (HRPCA) Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Hormone Refractory Prostate Cancer (HRPCA) Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, intensifying HRPCA prevalence and fast-emerging treatment modifications, the global HRPCA market is poised to witness an unprecedented growth.

        The global Hormone Refractory Prostate Cancer (HRPCA) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Hormone Refractory Prostate Cancer (HRPCA) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hormone Refractory Prostate Cancer (HRPCA) market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Hormone Refractory Prostate Cancer (HRPCA) in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Hormone Refractory Prostate Cancer (HRPCA) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Astellas Inc
        Sanofi S.A
        Dendreon Corporation, Bayer AG
        Johnson & Johnson
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Chemotherapy
        Hormonal Therapy
        Immunotherapy
        Radiation Therapy
        Surgery

        Segment by Application
        Hospitals
        Ambulatory Surgical Centers
        Specialty Clinics


        Summary:
        Get latest Market Research Reports on Hormone Refractory Prostate Cancer (HRPCA). Industry analysis & Market Report on Hormone Refractory Prostate Cancer (HRPCA) is a syndicated market report, published as Global Hormone Refractory Prostate Cancer (HRPCA) Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Hormone Refractory Prostate Cancer (HRPCA) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,713.45
        4,070.17
        5,426.90
        3,141.64
        4,712.45
        6,283.27
        379,907.50
        569,861.25
        759,815.00
        248,972.15
        373,458.23
        497,944.30
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report